These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16922260

  • 1. Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities.
    Decker RH, Tanoue LT, Colasanto JM, Detterbeck FC, Wilson LD.
    Oncology (Williston Park); 2006 Jul; 20(8):899-905; discussion 905-8, 913. PubMed ID: 16922260
    [Abstract] [Full Text] [Related]

  • 2. Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: Assessment and conventional radiotherapy.
    Decker RH, Tanoue LT, Colasanto JM, Detterbeck FC, Wilson LD.
    Oncology (Williston Park); 2006 Jun; 20(7):727-36. PubMed ID: 16841796
    [Abstract] [Full Text] [Related]

  • 3. Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: advances and controversies in the management of early stage non-small cell lung cancer.
    Pennathur A, Abbas G, Christie N, Landreneau R, Luketich JD.
    Curr Opin Pulm Med; 2007 Jul; 13(4):267-70. PubMed ID: 17534171
    [Abstract] [Full Text] [Related]

  • 4. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials.
    Powell JW, Dexter E, Scalzetti EM, Bogart JA.
    Lancet Oncol; 2009 Sep; 10(9):885-94. PubMed ID: 19717090
    [Abstract] [Full Text] [Related]

  • 5. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS, Schytte T, Jensen HR, Brink C, Hansen O.
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [Abstract] [Full Text] [Related]

  • 6. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer.
    Lanuti M, Sharma A, Digumarthy SR, Wright CD, Donahue DM, Wain JC, Mathisen DJ, Shepard JA.
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):160-6. PubMed ID: 19154919
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT, Wu X, Fayad F, Fowler JF, Amendola BE, García S, Han H, de la Zerda A, Bossart E, Huang Z, Schwade JG.
    Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
    [Abstract] [Full Text] [Related]

  • 9. Evaluation and treatment of high-risk patients with early-stage lung cancer.
    Mehta HJ, Ross C, Silvestri GA, Decker RH.
    Clin Chest Med; 2011 Dec; 32(4):783-97. PubMed ID: 22054886
    [Abstract] [Full Text] [Related]

  • 10. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.
    Lee DS, Kim YS, Yoo IeR, Kang YN, Kim SJ, Oh JK, Kim YK, Wang YP, Park JG, Kang JH, Han DH, Ahn MI, Lee KY.
    Lung Cancer; 2013 May; 80(2):172-8. PubMed ID: 23489556
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 12. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [Abstract] [Full Text] [Related]

  • 13. Role of stereotactic body radiation therapy and proton/carbon nuclei therapies.
    Williams TM, Maier A.
    Cancer J; 2013 Jan; 19(3):272-81. PubMed ID: 23708074
    [Abstract] [Full Text] [Related]

  • 14. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM, Sandhu TS, Lattin PB, Chang JH, Lee CK, Groshko GA, Lattin CJ.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):707-15. PubMed ID: 18455322
    [Abstract] [Full Text] [Related]

  • 15. New therapeutic approaches for early stage non-small cell lung cancer.
    El-Sherif A, Luketich JD, Landreneau RJ, Fernando HC.
    Surg Oncol; 2005 Jul 01; 14(1):27-32. PubMed ID: 15777887
    [Abstract] [Full Text] [Related]

  • 16. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
    Guillerme F, Clavier JB, Schumacher C, Falcoz PE, Bourrhala K, Santelmo N, Hassler S, Schott R, Quoix E, Massard G, Noël G.
    Cancer Radiother; 2013 Jul 01; 17(4):272-81. PubMed ID: 23712043
    [Abstract] [Full Text] [Related]

  • 17. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
    Brown WT, Wu X, Amendola B, Perman M, Han H, Fayad F, Garcia S, Lewin A, Abitbol A, de la Zerda A, Schwade JG.
    Cancer J; 2007 Jul 01; 13(2):87-94. PubMed ID: 17476136
    [Abstract] [Full Text] [Related]

  • 18. High-dose fractionated radiotherapy to 80 Gy for stage I-II medically inoperable non-small-cell lung cancer.
    Watkins JM, Wahlquist AE, Zauls AJ, Fields EC, Garrett-Mayer E, Aguero EG, Silvestri GA, Sharma AK.
    J Med Imaging Radiat Oncol; 2010 Dec 01; 54(6):554-61. PubMed ID: 21199434
    [Abstract] [Full Text] [Related]

  • 19. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
    Iyengar P, Westover K, Timmerman RD.
    Semin Respir Crit Care Med; 2013 Dec 01; 34(6):845-54. PubMed ID: 24258574
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):348-53. PubMed ID: 22104360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.